RNTX 8-K 2026-09-04

Rein Therapeutics, Inc. (RNTX) 8-K dated 2026-09-04 — accession 0001193125-26-383726. This URL is the filing, not the RNTX hub.

Rein Therapeutics, Inc. (RNTX) is a biotechnology company listed on NASDAQ.

Rein Therapeutics, Inc. filed a 8-K on 2026-09-04. Accession 0001193125-26-383726.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.

Not investment advice. The RNTX SEC hub lists recent forms. The stock page is the research view.